2021
DOI: 10.6118/jmm.21022
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of the Complementary and Alternative Therapies for the Management of Psychological Symptoms of Menopause: A Systematic Review of Randomized Controlled Trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 66 publications
0
12
0
Order By: Relevance
“…In conclusion, our ndings showed that soy peptides attenuate aggression, hyperactivity, and cognitive dysfunction in mice by preventing neuronal abnormalities and also affect the microbiota composition. Accumulating evidence indicates that long-term dietary supplementation has bene cial effects on cellular functions and is nearly as effective as medication for mental health without adverse effects 59 . Considering that soy peptides have a preventive effect on age-related cognitive decline by modulating synaptic plasticity-associated proteins 34 , daily intake of soy peptides may be useful in preventing progressive deterioration of synaptic function caused by aging and juvenile chronic stress.…”
Section: Discussionmentioning
confidence: 99%
“…In conclusion, our ndings showed that soy peptides attenuate aggression, hyperactivity, and cognitive dysfunction in mice by preventing neuronal abnormalities and also affect the microbiota composition. Accumulating evidence indicates that long-term dietary supplementation has bene cial effects on cellular functions and is nearly as effective as medication for mental health without adverse effects 59 . Considering that soy peptides have a preventive effect on age-related cognitive decline by modulating synaptic plasticity-associated proteins 34 , daily intake of soy peptides may be useful in preventing progressive deterioration of synaptic function caused by aging and juvenile chronic stress.…”
Section: Discussionmentioning
confidence: 99%
“…A survey of epidemiology in China showed that perimenopausal women experienced anxiety in 81.58%, mild to moderate anxiety in 68.42%, depression in 85.09%, and mild to moderate depression in 73.68% ( 41 ). Mehrnoush et al ( 42 ) showed that menopause is not a high-risk period for mental illness but causes psychological problems, the most common of which are anxiety and depression, which impair their ability to cope with events in daily life and work, and reduce the quality of life of women. Herson et al ( 43 ) have shown that women not only have an increased risk of depression and anxiety during the perimenopausal and menopausal transition (MT) periods, but also experience higher severity of depressive symptoms during the perimenopausal period compared with before and after menopause.…”
Section: Discussionmentioning
confidence: 99%
“…Other botanical supplements. Several other botanicals have been trialled for treating depressive symptoms during menopause (Johnson et al, 2019;Mehrnoush et al, 2021). However, the available evidence was typically limited to a single RCT, and not all interventions reported a significant improvement in depressive or psychological symptoms.…”
Section: Food and Botanical Supplementsmentioning
confidence: 99%